Paper21272136
High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease.
Wang TY and 6 others. Nephrology (Carlton), 2011. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease. Papers, record 21272136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21272136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Transitional Cell | Major topic |
| Kidney Failure, Chronic | Major topic |
| Urologic Neoplasms | Major topic |
| Aged | |
| Female | |
| Humans | |
| Incidence | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Neoplasm Recurrence, Local | |
| Peritoneal Dialysis | |
| Regression Analysis | |
| Renal Dialysis | |
| Risk Factors | |
| Taiwan | |
| Treatment Outcome |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39659915 | Recurrence risk of erythropoiesis-stimulating agents on early-stage urothelial carcinoma in patients with end stage renal disease. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39659915 | PubMed |
| 39090146 | No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomy. | Sci Rep | 2024 | https://conductscience.org/library/papers/39090146 | PubMed |
| 38593276 | NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas. | Kaohsiung J Med Sci | 2024 | https://conductscience.org/library/papers/38593276 | PubMed |
| 34829313 | Treatment Strategy for Dialysis Patient with Urothelial Carcinoma. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34829313 | PubMed |
| 31261684 | Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31261684 | PubMed |
| 29069858 | Hepatocellular carcinoma in hemodialysis patients. | Oncotarget | 2017 | https://conductscience.org/library/papers/29069858 | PubMed |
| 27275607 | Oral Tori in Chronic Peritoneal Dialysis Patients. | PLoS One | 2016 | https://conductscience.org/library/papers/27275607 | PubMed |
| 27057873 | Chronic Kidney Disease is Associated With Upper Tract Urothelial Carcinoma: A Nationwide Population-Based Cohort Study in Taiwan. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27057873 | PubMed |
| 26220096 | Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis. | Clin Transl Oncol | 2016 | https://conductscience.org/library/papers/26220096 | PubMed |
| 25918724 | Oral tori in chronic hemodialysis patients. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25918724 | PubMed |
| 25431765 | Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25431765 | PubMed |
| 25177705 | Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25177705 | PubMed |
| 23674847 | Hepatocellular carcinoma in patients with chronic kidney disease. | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/23674847 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21272136
GET https://conductscience.org/api/papers/v1/21272136/authors